Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$26.2M Sell
592,501
-16,446
-3% -$750K 0.03% 556
2023
Q4
$28M Sell
608,947
-109,914
-15% -$4.67M 0.03% 564
2023
Q3
$30.9M Sell
718,861
-27,210
-4% -$1.27M 0.03% 518
2023
Q2
$35.6M Buy
746,071
+23,711
+3% +$1.14M 0.04% 492
2023
Q1
$35.2M Sell
722,360
-42,625
-6% -$2.17M 0.04% 507
2022
Q4
$40.5M Sell
764,985
-83,462
-10% -$4.11M 0.04% 460
2022
Q3
$37.1M Buy
848,447
+64,289
+8% +$3.18M 0.04% 476
2022
Q2
$39.2M Buy
784,158
+112,655
+17% +$5.5M 0.04% 477
2022
Q1
$34.9M Buy
671,503
+116,530
+21% +$6.01M 0.03% 582
2021
Q4
$32.7M Sell
554,973
-130,763
-19% -$7.5M 0.02% 840
2021
Q3
$37.6M Sell
685,736
-670,585
-49% -$37.3M 0.02% 764
2021
Q2
$71M Sell
1,356,321
-471,097
-26% -$24.3M 0.04% 515
2021
Q1
$94.4M Buy
1,827,418
+982,231
+116% +$54M 0.05% 432
2020
Q4
$47.4M Sell
845,187
-1,679,888
-67% -$89.6M 0.02% 743
2020
Q3
$140M Sell
2,525,075
-7,178,295
-74% -$372M 0.09% 257
2020
Q2
$440M Buy
9,703,370
+4,237,709
+78% +$190M 0.32% 57
2020
Q1
$241M Buy
5,465,661
+3,325,660
+155% +$130M 0.21% 93
2019
Q4
$76.7M Buy
2,140,001
+963,648
+82% +$35.8M 0.06% 376
2019
Q3
$41.1M Buy
1,176,353
+158,934
+16% +$6.11M 0.03% 546
2019
Q2
$43.7M Sell
1,017,419
-112,230
-10% -$4.65M 0.04% 501
2019
Q1
$48.7M Buy
1,129,649
+98,938
+10% +$3.98M 0.04% 436
2018
Q4
$37.7M Sell
1,030,711
-81,492
-7% -$3.03M 0.04% 486
2018
Q3
$44.7M Sell
1,112,203
-34,238
-3% -$1.37M 0.04% 464
2018
Q2
$44M Sell
1,146,441
-35,021
-3% -$1.29M 0.04% 435
2018
Q1
$40.5M Buy
1,181,462
+67,199
+6% +$2.36M 0.04% 498
2017
Q4
$36.5M Sell
1,114,263
-38,866
-3% -$1.34M 0.03% 559
2017
Q3
$38.5M Buy
1,153,129
+195,404
+20% +$6.73M 0.04% 515
2017
Q2
$34.1M Sell
957,725
-312,962
-25% -$10.6M 0.03% 544
2017
Q1
$39M Buy
+1,270,687
New +$39.2M 0.04% 524

Other funds holding QGEN

Credit Suisse's QGEN Position: Q1 2024 in Review

Credit Suisse reduced its Qiagen (QGEN) stake by 2.7% in Q1 2024, selling an estimated $750K and leaving 592,501 shares worth $26.2M. The position accounts for 0.03% of the portfolio, ranked #556.

Credit Suisse first reported a position in QGEN in Q1 2017 and has held it in 29 quarters since. The position peaked at $440M in Q2 2020. 282 funds tracked by Wall St. Rank hold QGEN as of Q1 2024.

  • Credit Suisse held 592,501 shares of Qiagen worth $26.2M as of Q1 2024.
  • Credit Suisse sold 16,446 Qiagen shares in Q1 2024, an estimated $750K.
  • Qiagen made up 0.03% of Credit Suisse's portfolio in Q1 2024, its #556 holding.
  • Credit Suisse first reported a position in Qiagen in Q1 2017 and has held it in 29 quarters since.
  • Credit Suisse's Qiagen position peaked at $440M in Q2 2020.
  • 282 funds tracked by Wall St. Rank held Qiagen as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.